No Surprises in Pricing, Label for Gilead's Four-Drug Stribild
Gilead Sciences Inc. said it expects to have its four-drug, single-tablet regimen Stribild, formerly known as Quad, available to patients by the end of this week, following the drug's approval Monday for treatment-naïve patients with HIV-1 infection.
Suite: 1100 | Atlanta, Georgia 30346, USA
Outside of the US
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
Sign up for Highlights FREE e-mail newsletter